These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 26189876)
1. Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study. Mathieu R; Klatte T; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Sun M; Lotan Y; Scherr DS; Montorsi F; Briganti A; Rouprêt M; Margulis V; Rink M; Kluth LA; Rieken M; Kenner L; Susani M; Robinson BD; Xylinas E; Loidl W; Shariat SF BJU Int; 2016 Aug; 118(2):243-9. PubMed ID: 26189876 [TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441 [TBL] [Abstract][Full Text] [Related]
3. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. Fajkovic H; Mathieu R; Lucca I; Hiess M; Hübner N; Al Hussein Al Awamlh B; Lee R; Briganti A; Karakiewicz P; Lotan Y; Roupret M; Rink M; Kluth L; Loidl W; Seitz C; Klatte T; Kramer G; Susani M; Shariat SF Urol Oncol; 2016 May; 34(5):233.e1-6. PubMed ID: 26973136 [TBL] [Abstract][Full Text] [Related]
4. Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study. Mathieu R; Lucca I; Vartolomei MD; Mbeutcha A; Klatte T; Seitz C; Karakiewicz PI; Fajkovic H; Sun M; Lotan Y; Montorsi F; Briganti A; Rouprêt M; Margulis V; Rink M; Rieken M; Kenner L; Susani M; Wolgang L; Shariat SF BJU Int; 2017 Feb; 119(2):234-238. PubMed ID: 26940243 [TBL] [Abstract][Full Text] [Related]
5. The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy. Sevcenco S; Mathieu R; Baltzer P; Klatte T; Fajkovic H; Seitz C; Karakiewicz PI; Rouprêt M; Rink M; Kluth L; Trinh QD; Loidl W; Briganti A; Scherr DS; Shariat SF Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):163-7. PubMed ID: 26810014 [TBL] [Abstract][Full Text] [Related]
6. Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study. Maj-Hes AB; Mathieu R; Özsoy M; Soria F; Moschini M; Abufaraj M; Briganti A; Roupret M; Karakiewicz PI; Klatte T; Shariat SF Urol Oncol; 2017 Jul; 35(7):460.e1-460.e8. PubMed ID: 28460801 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy. Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360 [TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients. Satoh T; Yang G; Egawa S; Addai J; Frolov A; Kuwao S; Timme TL; Baba S; Thompson TC Cancer; 2003 Mar; 97(5):1225-33. PubMed ID: 12599229 [TBL] [Abstract][Full Text] [Related]
9. Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score. Hansen J; Bianchi M; Sun M; Rink M; Castiglione F; Abdollah F; Steuber T; Ahyai SA; Steurer S; Göbel C; Freschi M; Montorsi F; Shariat SF; Fisch M; Graefen M; Karakiewicz PI; Briganti A; Chun FK BJU Int; 2014 Mar; 113(3):399-407. PubMed ID: 24053339 [TBL] [Abstract][Full Text] [Related]
10. Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer. Gannon PO; Lessard L; Stevens LM; Forest V; Bégin LR; Minner S; Tennstedt P; Schlomm T; Mes-Masson AM; Saad F Eur J Cancer; 2013 Jul; 49(10):2441-8. PubMed ID: 23541563 [TBL] [Abstract][Full Text] [Related]
11. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies. Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411 [TBL] [Abstract][Full Text] [Related]
12. Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy. Mathieu R; Shariat SF; Seitz C; Karakiewicz PI; Fajkovic H; Sun M; Lotan Y; Scherr DS; Tewari A; Montorsi F; Briganti A; Rouprêt M; Lucca I; Margulis V; Rink M; Kluth LA; Rieken M; Bachman A; Xylinas E; Robinson BD; Bensalah K; Margreiter M World J Urol; 2015 Aug; 33(8):1165-71. PubMed ID: 25344896 [TBL] [Abstract][Full Text] [Related]
13. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Rieken M; Shariat SF; Kluth LA; Fajkovic H; Rink M; Karakiewicz PI; Seitz C; Briganti A; Rouprêt M; Loidl W; Trinh QD; Bachmann A; Pourmand G Eur Urol; 2015 Dec; 68(6):949-56. PubMed ID: 26050111 [TBL] [Abstract][Full Text] [Related]
14. Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study. Lughezzani G; Lazzeri M; Buffi NM; Abrate A; Mistretta FA; Hurle R; Pasini L; Castaldo L; Zandegiacomo De Zorzi S; Peschechera R; Fiorini G; Taverna G; Casale P; Guazzoni G Urol Oncol; 2015 Aug; 33(8):337.e7-14. PubMed ID: 26055430 [TBL] [Abstract][Full Text] [Related]
15. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy. Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience. Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548 [TBL] [Abstract][Full Text] [Related]
17. Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model. Lucca I; Shariat SF; Briganti A; Lotan Y; Roehrborn CG; Montorsi F; Remzi M; Seitz C; Fajkovic H; Klingler C; Karakiewicz PI; Sun M; Rouprêt M; Loidl W; Pummer K; Klatte T Urol Oncol; 2015 Feb; 33(2):71.e21-6. PubMed ID: 25443275 [TBL] [Abstract][Full Text] [Related]
18. Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy. Pagano MJ; Whalen MJ; Paulucci DJ; Reddy BN; Matulay JT; Rothberg M; Scarberry K; Patel T; Shapiro EY; RoyChoudhury A; McKiernan J; Benson MC; Badani KK Prostate; 2016 Feb; 76(2):226-34. PubMed ID: 26481325 [TBL] [Abstract][Full Text] [Related]
19. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy. Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]